Ceftizoxime Sodium

头孢唑肟钠

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameCeftizoxime Sodium
Drug Alias Name头孢唑肟FR-13749FK-749
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics > Third-generation cephalosporins
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1983/09/15
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesAurora Optoelectronics Co LtdNihon GenericChoseido Pharmaceutical Co Ltd
Inactive CompaniesAstellas Pharma Inc
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01DD07
Related LinksWikipediaDrugBankKEGG